Stockscreener 앱 받기
6.87
1.43%
-0.10
시장 영업 전:
6.98
0.11
+1.60%
전일 마감가:
$6.97
열려 있는:
$6.89
하루 거래량:
467.41K
Relative Volume:
2.20
시가총액:
$2.33B
수익:
$417.75M
순이익/손실:
$32.27M
주가수익비율:
70.46
EPS:
0.0975
순현금흐름:
-
1주 성능:
+1.18%
1개월 성능:
-3.65%
6개월 성능:
-24.34%
1년 성능:
-60.77%
1일 변동 폭
$6.77
$6.91
1주일 범위
$6.69
$7.52
52주 변동 폭
$6.28
$20.00
Telix Pharmaceuticals Ltd Adr Stock (TLX) Company Profile
Compare TLX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLX
Telix Pharmaceuticals Ltd Adr
|
6.87 | 2.36B | 417.75M | 32.27M | 0 | 0.0975 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.89 | 120.48B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.50 | 81.05B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
749.56 | 46.33B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
327.30 | 42.26B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
299.02 | 32.87B | 5.36B | 287.73M | 924.18M | 2.5229 |
Telix Pharmaceuticals Ltd Adr Stock (TLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Citigroup | Buy |
| 2025-08-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2025-07-03 | 개시 | H.C. Wainwright | Buy |
| 2025-06-05 | 개시 | Wedbush | Outperform |
| 2024-11-15 | 개시 | UBS | Buy |
Telix Pharmaceuticals Ltd Adr 주식(TLX)의 최신 뉴스
Investor Education Webinar - GlobeNewswire Inc.
Global prostate scan registry taps AI to predict survival - Stock Titan
Wall Street Bullish on Telix Pharmaceuticals (TLX), Here's Why - Finviz
Telix leaders to speak at Oppenheimer and TD Cowen, sessions streamed live - Stock Titan
Stock of the day: Telix Pharmaceuticals - ig.com
Has Adlai Nortye Ltd. Sponsored ADR (ANL) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Telix submits European marketing application for brain cancer imaging agent By Investing.com - Investing.com India
Telix Pharmaceuticals stock rises after European regulatory submission By Investing.com - Investing.com India
Sea Limited Sponsored ADR (SE) Rises Higher Than Market: Key Facts - Yahoo Finance
New Telix brain scan aims to distinguish tumor growth from treatment effects - Stock Titan
Are Investors Undervaluing Yankuang Energy Group Company Limited Sponsored ADR (YZCAY) Right Now? - Yahoo Finance
Here's Why PDD Holdings Inc. Sponsored ADR (PDD) Fell More Than Broader Market - Yahoo Finance
Sea Limited Sponsored ADR (SE) Advances While Market Declines: Some Information for Investors - Yahoo Finance
Is ANZ Group Holdings LimitedSponsored ADR (ANZGY) Outperforming Other Finance Stocks This Year? - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
Li Auto Inc. Sponsored ADR (LI) Advances While Market Declines: Some Information for Investors - Yahoo Finance
XPeng Inc. Sponsored ADR (XPEV) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Sea Limited Sponsored ADR (SE) Dips More Than Broader Market: What You Should Know - Yahoo Finance
RBC Capital upgrades Telix Pharmaceuticals stock rating to Outperform - Investing.com
Telix begins phase 3 trial to reduce prostate cancer biopsies - Investing.com South Africa
Telix Pharmaceuticals Within The Evolving Precision Oncology Space - Kalkine Media
Telix Pharmaceuticals Ltd. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Sahm
Here's What Analysts Think About Telix Pharmaceuticals (TLX) - Finviz
Shareholders that lost money on Telix Pharmaceuticals Ltd.(TLX) should contact The Gross Law Firm about pending Class ActionTLX - Sahm
Telix Pharmaceuticals Ltd. Sued for Securities Law ViolationsContact Levi & Korsinsky Before January 9, 2026 to Discuss Your RightsTLX - Finviz
Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman - Barchart.com
Health conference talk to spotlight Telix therapeutic pipeline and products - Stock Titan
Sea Limited Sponsored ADR (SE) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
New Strong Buy Stocks for January 6th - Yahoo Finance
TLX 6-DAY DEADLINE ALERT: Hagens Berman Urges Telix Investors to Act by Jan. 9 in Class Action Suit Over SEC Subpoena & FDA CRL on Manufacturing Failures - Sahm
FCX IMPORTANT DEADLINE: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Freeport-McMoRan Inc. Investors to Secure Counsel Before Important January 12 Deadline in Securities Class Action First Filed by the Firm - GlobeNewswire Inc.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 9, 2026 in Telix Pharmaceuticals Ltd. LawsuitTLX - Sahm
TLX DEADLINE: Faruqi & Faruqi Reminds Telix Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of January 9, 2026 - Barchart.com
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Class Action Filed Against Telix Pharmaceuticals Ltd. (TLX)January 9, 2026 Deadline to JoinContact Levi & Korsinsky - Sahm
Are Investors Undervaluing ENGIESponsored ADR (ENGIY) Right Now? - Yahoo Finance
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages F5, Inc. Stockholders to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Is Grupo Cibest S.A.Sponsored ADR (CIB) Stock Outpacing Its Conglomerates Peers This Year? - Yahoo Finance
Prostate scans reshaped treatment for 67% of men in China trial - Stock Titan
[6-K] Telix Pharmaceuticals Ltd Current Report (Foreign Issuer) | TLX SEC FilingForm 6-K - Stock Titan
Shareholders who lost money in shares of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) Should Contact Wolf Haldenstein Immediately - Finviz
Telix Pharma (TLX) Makes Progress With New Study - Finviz
RBC Capital initiates Telix Pharmaceuticals stock with Sector Perform rating - Investing.com
Telix Pharmaceuticals Ltd Adr (TLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
6.00%
자본화:
|
볼륨(24시간):